P4-347: Tau aggregation inhibitor (TAI) therapy with rember™ arrests the trajectory of rCBF decline in brain regions affected by Tau pathology in mild and moderate Alzheimer's disease (AD)

✍ Scribed by Staff, Roger T.; Ahearn, Trevor S.; Murray, Alison D.; Bentham, Peter; Seng, Kwang Meng; Wischik, Claude

• Book ID: 122433855
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 104 KB
• Volume: 4
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2008.05.2417